BackDermTech Overview

DermTech Long Term Debt

Track DermTech's long-term debt ($50M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$50.46M
↓ 6.09% YoYΔ $-3.27M vs prior year quarter

Peer average

Loading

DermTech Long Term Debt History

Loading

DermTech vs. peers: Long Term Debt Comparison

Loading

DermTech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

DermTech (DMTK) FAQ

DermTech (DMTK) currently reports a long-term debt of $50M as of March 2024. That compares with $54M in the prior-year period — down 6.1% year over year. Use the charts on this page to explore DermTech's long-term debt history and peer comparisons.

DermTech's long-term debt decreased from $54M to $50M — a 6.1% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DermTech reported $50M in long-term debt as of March 2024. That compares with $54M in the prior-year period — down 6.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $50M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DermTech, and consider following DMTK for alerts when major investors trade the stock.

DermTech is classified in the Healthcare sector. On long-term debt, it currently shows $50M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMTK with unrelated industries.